Sociedad Americana de Hirudoterapia

Linda K.

Chronic Venous Insufficiency with Venous Ulcer

58 · Portland, Oregon2024–202514Registros médicos verificados
Úlcera venosa (IVC)Manejo de heridas crónicas

Como enfermera, pensé que lo sabía todo sobre el cuidado de heridas. Pero cuando desarrollé mi propia úlcera venosa que no cicatrizaba, me di cuenta de cuán poco entendía lo que realmente pasan los pacientes. La hirudoterapia fue la pieza que faltaba para que mi herida finalmente cerrara después de ocho meses de frustración.

Linda K.

Linda K., a 58-year-old registered nurse from Portland, Oregon, shares her experience living with severe chronic venous insufficiency (CVI) and how leech therapy helped heal a persistent venous ulcer when standard treatments failed.

Background: A Nurse's Health Journey

Linda worked as an ICU nurse for nearly three decades. Prolonged standing, heavy lifting, and family history of venous disease led to CVI diagnosis in 2016. Despite compression stockings, leg elevation, weight loss (25 lbs), and walking programs, her disease kept progressing. By 2020, she had developed lipodermatosclerosis.

The compression stockings helped, but they were uncomfortable and hot. I was compliant, but my disease kept progressing. By 2020, I had developed lipodermatosclerosis — that hard, leathery skin around my ankles. I knew I was heading toward ulcers.

patient-stories.stories.cvi-venous-ulcer.sections.background.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.treatment.title

patient-stories.stories.cvi-venous-ulcer.sections.treatment.content

patient-stories.stories.cvi-venous-ulcer.sections.treatment.quote

patient-stories.stories.cvi-venous-ulcer.sections.treatment.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.experience.title

patient-stories.stories.cvi-venous-ulcer.sections.experience.content

patient-stories.stories.cvi-venous-ulcer.sections.experience.quote

patient-stories.stories.cvi-venous-ulcer.sections.experience.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.challenges.title

patient-stories.stories.cvi-venous-ulcer.sections.challenges.content

patient-stories.stories.cvi-venous-ulcer.sections.challenges.quote

patient-stories.stories.cvi-venous-ulcer.sections.challenges.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.title

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.content

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.quote

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.reflections.title

patient-stories.stories.cvi-venous-ulcer.sections.reflections.content

patient-stories.stories.cvi-venous-ulcer.sections.reflections.quote

patient-stories.stories.cvi-venous-ulcer.sections.reflections.quoteAttribution

Key Outcomes

Wound 80% reduced in 4 weeks
Complete healing in 5 weeks (after 8 months failed standard care)
14 months ulcer-free
Returned to part-time nursing
Cost-effective vs. continued wound care
patient-stories.stories.cvi-venous-ulcer.keyOutcomes.5

Perspectiva médica

Médico tratante

Dr. Raj Patel, MD

Physical Medicine & Rehabilitation, Wound Care

Linda's case exemplifies appropriate use of leech therapy as adjunctive treatment for refractory venous ulcer. The 80% wound size reduction in 4 weeks significantly exceeded typical healing rates with standard care alone. Key success factors: adequate arterial circulation (ABI >1.0), failed 4+ months standard care, compliant patient, and proper technique with periwound application.

Aviso médico

Los resultados individuales varían. Estas historias representan experiencias personales y no son garantía de resultados. La hirudoterapia requiere supervisión médica adecuada. Consulte a un profesional de salud calificado antes de iniciar cualquier tratamiento.

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.